AOD9604 Benefits: HGH Fragment for Metabolic Research

Discover AOD9604, the synthetic HGH fragment peptide studied for targeted fat metabolism, lipolysis, and body composition research without IGF-1 elevation.

## What Is AOD9604? AOD9604, also known as AOD 9604, is a synthetic peptide derived from the C-terminal fragment of human growth hormone (hGH). Specifically, it is a modified version of amino acids 177-191 with an added tyrosine at the N-terminus for stability. Originally developed for obesity research, this lipolytic peptide has become a staple in metabolic and fat-loss studies. Unlike full-length growth hormone, AOD9604 focuses purely on fat metabolism. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) without raising IGF-1 levels or affecting blood sugar and insulin sensitivity. ## How AOD9604 Works AOD9604 targets adipose tissue directly. It activates lipolytic pathways, particularly through beta-3 adrenergic receptors, while inhibiting acetyl-CoA carboxylase — an enzyme crucial for fat storage. This dual action promotes the release of stored fat for energy use and prevents new fat accumulation, especially in stubborn areas like the abdomen. Because it lacks the growth-promoting effects of complete hGH, researchers value AOD9604 for studying targeted fat reduction without the broader hormonal side effects. ## Key Research Findings on AOD9604 Early clinical trials showed promising results for weight management: - In one 12-week phase II study, participants receiving 1 mg daily of AOD9604 lost approximately 2.6 kg compared to 0.8 kg in the placebo group. - The peptide demonstrated particular effectiveness at reducing abdominal fat. - Six human clinical trials confirmed that AOD9604 is generally well tolerated with a favorable safety profile. Animal studies further supported its lipolytic effects, showing significant reductions in body weight gain and increased fat breakdown. ## AOD9604 vs HGH Fragment 176-191 AOD9604 is often compared to HGH Fragment 176-191. While both target fat loss, AOD9604 is a modified analog designed for greater stability and potentially better research outcomes. It offers the same core fat-burning benefits while maintaining a strong safety record in preclinical and clinical settings. ## Why Researchers Choose AOD9604 - **Targeted Fat Loss**: Supports reduction of stubborn adipose tissue. - **No IGF-1 Elevation**: Avoids the growth-related effects associated with full HGH. - **Favorable Safety Data**: Shown to be well tolerated across multiple studies. - **Metabolic Research Tool**: Ideal for investigating lipolysis, body composition, and obesity-related pathways. ## Research-Grade AOD9604 **Important Research Notice:** AOD9604 is sold by Amino Fuel Labs strictly for laboratory research and in vitro use only. It is not FDA-approved for human consumption or therapeutic use. For scientists and research facilities looking for high-purity AOD 9604, we provide independently tested peptides with fast domestic shipping. ## Explore More Research Peptides Browse our full selection of research peptides, including [MOTS-c](/peptides/mots-c), [5-Amino-1MQ](/peptides/5-amino-1mq), [SLU-PP-332](/peptides/slu-pp-332), and [Retatrutide](/peptides/retatrutide). Have questions about AOD9604 protocols or how it compares to other fat-loss peptides in your research? Leave a comment below or reach out — our team is here to support your work. *This article is for educational and research purposes only. AOD9604 is sold for research use only and is not intended for human consumption.*

AOD9604 Benefits: The Fat-Burning HGH Fragment for Metabolic Research